Malignant Colorectal Neoplasm — Research

Malignant Colorectal Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-13	169,282	`("Malignant Colorectal Neoplasm"[tiab] OR "Colorectal Cancer"[tiab] OR "Malignant Colorectal Tumor"[tiab])`	2026-09-13	pubmed
Last 5 years	2021-01-01 → 2026-12-31	65,243	`("Malignant Colorectal Neoplasm"[tiab] OR "Colorectal Cancer"[tiab] OR "Malignant Colorectal Tumor"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-13	pubmed
Last 12 months	2025-09-13 → 2026-09-13	14,135	`("Malignant Colorectal Neoplasm"[tiab] OR "Colorectal Cancer"[tiab] OR "Malignant Colorectal Tumor"[tiab]) AND (2025/09/13:2026/09/13[dp])`	2026-09-13	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (357)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 226–250 of 357 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
· Carcinogenesis · 2015 · PMID 26442524 · validated civic_curation pubmed
Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancer.
· Ann Oncol · 2015 · PMID 26371285 · validated civic_curation pubmed
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.
· Mol Cancer Ther · 2016 · PMID 27037411 · validated civic_curation pubmed
Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.